Scroll.in The Jan Vishwas Bill, 2023, passed by Lok Sabha on July 27, is in the news for its lenient approach to the crime of manufacturing “not of standard quality” (NSQ) drugs. But comparatively less attention is being paid to the adverse impact that the legislation will have on an equally serious issue, which is the regulation of pharmacies that have a key role to play in India’s drug supply. To begin...
More »SEARCH RESULT
Poverty and inequality
KEY TRENDS • Oxfam India's 2023 India Supplement report on poverty and inequality in India reveals that the gap between the rich and the poor is widening. Following the pandemic in 2019, the bottom 50 per cent of the population have continued to see their wealth chipped away. By 2020, their income share was estimated to have fallen to only 13 per cent of the national income and have less than 3...
More »RBI reluctant to hand out NBFC licence to fintechs -Hamsini Karthik
-The Hindu Business Line PhonePe - ZestMoney deal to set precedence for fintechs to explore backdoor entry into the lending business Despite three months of engagement and continued discussions with the banking regulator, fintechs may not have cracked the code yet to operate as non-bank lenders. Highly placed sources say the Reserve Bank of India is reluctant to issue non-bank finance company or NBFC licences to fintechs. PhonePe, Razorpay, BharatPe, Khatabook, OkCredit and...
More »Expired pill: Editorial on new drugs and cosmetics bill
-The Telegraph There is no mention of compliance with ‘good manufacturing practices’ or the need to make inspection reports public, leaving the process of regulation vague and dependent on whims of drug inspectors This month, the Union ministry of health published the draft new drugs, medical devices and cosmetics bill to replace the antiquated Drugs and Cosmetics Act, 1940. Yet, most of the draft bill appears to be a copy of the...
More »Covid deaths: ‘Misleading’ tag on reply to World Health Organisation -GS Mudur
-The Telegraph Jon Wakefield picks holes in Narendra Modi government’s twin claims Jon Wakefield was disappointed. India’s health ministry had issued a statement decrying the methodology adopted by the World Health Organisation to estimate excess deaths worldwide during the Covid-19 pandemic in 2020 and 2021. The exercise indicated 4.7 million excess deaths in India, 9.8 times the country’s official Covid-19 death toll. The ministry statement itself didn’t surprise Wakefield. Five times since July 2021,...
More »